Abbott Laboratories
Name | Area | Department | Start Year | Stop Year | Advisor |
---|---|---|---|---|---|
Min Zhang | Neuroscience Drug Discovery | 2003 | Lynne E. Rueter (research scientist) | ||
Janel M. Boyce-Rustay | Behavioral Pharmacology | ||||
Ana Maria Basso | Behavioral Neuroscience | ||||
Lynne E. Rueter | depression, schizophrenia, learning/memory | ||||
Kathy Chu | Neurophysiology | ||||
Mike Jarvis | |||||
Raymond Wieboldt | |||||
Jack A. Grebb | Schizophrenia, substance abuse and signal transduction | ||||
Klara Abravaya | 1998 | 1993 | Richard I. Morimoto (post-doc) | ||
Kaitlin E. Browman | 1998 | 2000 | John C. Crabbe (post-doc) | ||
Nathan R. Rustay | Cognition, Behavior | 1998 | 2004 | John C. Crabbe (grad student) | |
Michael E. Ballard | behavior, psychopharmacology, human neuroimaging, PET, fMRI, stimulants, cannabinoids, cognition, delay discounting, executive function, memory, emotional processing, working memory | 2003 | 2007 | Lynne E. Rueter (research scientist), Min Zhang (research scientist) | |
Donald J. Osterling | Cerebral Ischemia |